Zevra - ADHS - A Star is born (Seite 3)
eröffnet am 06.09.21 11:06:47 von
neuester Beitrag 03.06.24 18:30:47 von
neuester Beitrag 03.06.24 18:30:47 von
Beiträge: 42
ID: 1.352.190
ID: 1.352.190
Aufrufe heute: 1
Gesamt: 4.277
Gesamt: 4.277
Aktive User: 0
ISIN: US4884452065 · WKN: A2QLX7 · Symbol: 1GDA
4,3200
EUR
0,00 %
0,0000 EUR
Letzter Kurs 10.06.24 Tradegate
Neuigkeiten
| TitelBeiträge |
|---|
03.06.24 · globenewswire  |
09.05.24 · globenewswire |
08.05.24 · globenewswire |
01.05.24 · globenewswire |
Werte aus der Branche Biotechnologie
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 70,10 | +59,32 | |
| 0,9510 | +28,08 | |
| 26,19 | +25,91 | |
| 6,9600 | +23,40 | |
| 1,2270 | +23,32 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 0,7600 | -25,49 | |
| 3,8150 | -25,78 | |
| 3,4700 | -33,27 | |
| 0,5541 | -40,93 | |
| 0,9500 | -43,11 |
Beitrag zu dieser Diskussion schreiben
Feedback
doctor01
Bullish
05:21 PM
$KMPH
If you know of any other investment that is as much of a TOTAL NO BRAINER as KemPharm, please let me know and I will put some cash in it as well. Seriously, someone asked for people to post their buys. I have never done that with my position or buys, but I account for 10% of today's volume at this moment.
Why do I continue to buy KemPharm?
IT'S BECAUSE IT IS CURRENTLY LIKE PLAYING POKER AND I CAN SEE EVERYONE'S CARD AND I KNOW THAT I HAVE A WINNING HAND!
Yes, I am likely down more than any other investor at this point in time. However, I have had the wherewithal to ADD AT THESE LEVELS AND CLEARLY SEE WHAT WE HAVE AND WHERE WE ARE GOING. I am NOT hanging around because I am in the red. I am hanging around because I KNOW HOW MUCH GREEN I AM GOING TO HAVE from this investment. It's currently the best game in town!
https://stocktwits.com/doctor01/message/479431387
Bullish
05:21 PM
$KMPH
If you know of any other investment that is as much of a TOTAL NO BRAINER as KemPharm, please let me know and I will put some cash in it as well. Seriously, someone asked for people to post their buys. I have never done that with my position or buys, but I account for 10% of today's volume at this moment.
Why do I continue to buy KemPharm?
IT'S BECAUSE IT IS CURRENTLY LIKE PLAYING POKER AND I CAN SEE EVERYONE'S CARD AND I KNOW THAT I HAVE A WINNING HAND!
Yes, I am likely down more than any other investor at this point in time. However, I have had the wherewithal to ADD AT THESE LEVELS AND CLEARLY SEE WHAT WE HAVE AND WHERE WE ARE GOING. I am NOT hanging around because I am in the red. I am hanging around because I KNOW HOW MUCH GREEN I AM GOING TO HAVE from this investment. It's currently the best game in town!
https://stocktwits.com/doctor01/message/479431387
Pascoe ist ein toller Redner. 
Gestern Abend die Analystenkonferenz bei Canacord:
https://wsw.com/webcast/canaccord76/register.aspx?conf=canac…
Gestern Abend die Analystenkonferenz bei Canacord:
https://wsw.com/webcast/canaccord76/register.aspx?conf=canac…
s.S.22ff - ich muss die beiden wohl immer verwechselt haben 
https://cdn.coverstand.com/53489/753929/c2d948ce63998d43ee70…
https://cdn.coverstand.com/53489/753929/c2d948ce63998d43ee70…
Chart sieht gut aus, fundamental eh blendend.
Werd wohl nochmal nachtanken, um den fortlaufenden Wertverlust des Euro abzufedern. Muss man sich mal vorstellen, jetzt zahlt man 5 EUR die 5$ KMPH - das waren Anfang des Jahres beim Wechselkurs von 1.15 EUR/$ noch 4,35 EUR für 5$
Werd wohl nochmal nachtanken, um den fortlaufenden Wertverlust des Euro abzufedern. Muss man sich mal vorstellen, jetzt zahlt man 5 EUR die 5$ KMPH - das waren Anfang des Jahres beim Wechselkurs von 1.15 EUR/$ noch 4,35 EUR für 5$
Einfaches Einfügen von wallstreetONLINE Charts: So funktionierts.
From Redditors to creditors: Orphazyme's wild ride ends with $13M sale to satisfy bankruptcy court
"Orphazyme’s vertiginous decline is over. Having briefly commanded a market cap of $2.7 billion in June 2021, the Danish meme stock is now selling substantially all of its assets and business activities to KemPharm for $12.8 million in cash.
Last summer, day traders, spurred by chatter on Reddit, piled into Orphazyme ahead of an FDA decision about whether to approve its heat shock response amplifier arimoclomol in a rare lysosomal disorder. The activity dragged Orphazyme from relative obscurity, but the decline was as rapid as the rise, with the stock going from $5 to $77 and back down to $15 even before the FDA rejected the therapy..."
https://www.fiercebiotech.com/biotech/redditors-creditors-or…
"Orphazyme’s vertiginous decline is over. Having briefly commanded a market cap of $2.7 billion in June 2021, the Danish meme stock is now selling substantially all of its assets and business activities to KemPharm for $12.8 million in cash.
Last summer, day traders, spurred by chatter on Reddit, piled into Orphazyme ahead of an FDA decision about whether to approve its heat shock response amplifier arimoclomol in a rare lysosomal disorder. The activity dragged Orphazyme from relative obscurity, but the decline was as rapid as the rise, with the stock going from $5 to $77 and back down to $15 even before the FDA rejected the therapy..."
https://www.fiercebiotech.com/biotech/redditors-creditors-or…
Trading Spotlight
KemPharm Announces Strategic Acquisition of Arimoclomol from Orphazyme, Expanding its Rare CNS Diseases Pipeline
...
Under the terms of the agreement, KemPharm will purchase substantially all of the assets and operations of Orphazyme, including arimoclomol, for a cash payment of USD $12.8 million. The Company expects to finance the cash payment with a revolving line of credit secured by KemPharm’s balance sheet. KemPharm intends to retain the majority of Orphazyme’s current employees.
...
https://finance.yahoo.com/news/kempharm-announces-strategic-…
ORPHAZYME A/S UNDER IN-COURT-RESTRUCTURING TO SELL SUBSTANTIALLY ALL OF ITS ASSETS AND BUSINESS ACTIVITIES TO KEMPHARM, INC.
May 15, 2022 at 5:00 PM EDT
www.orphazyme.com
ORPH aktuell 0.24$ - vor gut einem Jahr gingen Stücke zu 77$ um
...
Under the terms of the agreement, KemPharm will purchase substantially all of the assets and operations of Orphazyme, including arimoclomol, for a cash payment of USD $12.8 million. The Company expects to finance the cash payment with a revolving line of credit secured by KemPharm’s balance sheet. KemPharm intends to retain the majority of Orphazyme’s current employees.
...
https://finance.yahoo.com/news/kempharm-announces-strategic-…
ORPHAZYME A/S UNDER IN-COURT-RESTRUCTURING TO SELL SUBSTANTIALLY ALL OF ITS ASSETS AND BUSINESS ACTIVITIES TO KEMPHARM, INC.
May 15, 2022 at 5:00 PM EDT
www.orphazyme.com
ORPH aktuell 0.24$ - vor gut einem Jahr gingen Stücke zu 77$ um
Einfaches Einfügen von wallstreetONLINE Charts: So funktionierts.
DoctorAcula
Bullish
10:23 AM
$KMPH
Insurance coverage is key!
UnitedHealthcare is the largest health insurance company in the U.S.
AZSTARYS WILL BE COVERED BY THE LARGEST HEALTH INSURANCE COMPANY IN THE US!!!
https://stocktwits.com/DoctorAcula/message/446995201
Bullish
10:23 AM
$KMPH
Insurance coverage is key!
UnitedHealthcare is the largest health insurance company in the U.S.
AZSTARYS WILL BE COVERED BY THE LARGEST HEALTH INSURANCE COMPANY IN THE US!!!
https://stocktwits.com/DoctorAcula/message/446995201
The KemPharm Story, as told by CEO and Co-Founder Travis Mickle.
Event: Cantor Global Healthcare Conference
Date: September 28, 2021
https://investors.kempharm.com/static-files/e19e6c26-f699-49…
Event: Cantor Global Healthcare Conference
Date: September 28, 2021
https://investors.kempharm.com/static-files/e19e6c26-f699-49…
Neues Video, Travis mit verwegenem Bart
Danke Corey und diese "Rechnung" beinhaltet erstmal nur Azstarys - SDX, die 450Mio US$ an Milestone Zahlungen und die 130Mio US$ Cash bei 300Mio MK (schuldenfrei) und der heutige China Kracher bleiben hierbei erstmal außen vor.
"Okay, let’s do some math.
Let’s assume KemPharm can eventually capture 10% of the $18 billion ADHD drug market. That’s $1.8 billion in revenue. If they get an average 15% royalty, ignoring the $450 million in milestone payments, that’s $270 million in gross profit. Assuming the milestone payments cover the fixed expenses, with 35 million shares outstanding, that’s EPS of $7.70.
With a 15-20 multiplier, that’s a share price of $115-155"
https://finance.yahoo.com/quote/KMPH/community?p=KMPH
"Okay, let’s do some math.
Let’s assume KemPharm can eventually capture 10% of the $18 billion ADHD drug market. That’s $1.8 billion in revenue. If they get an average 15% royalty, ignoring the $450 million in milestone payments, that’s $270 million in gross profit. Assuming the milestone payments cover the fixed expenses, with 35 million shares outstanding, that’s EPS of $7.70.
With a 15-20 multiplier, that’s a share price of $115-155"
https://finance.yahoo.com/quote/KMPH/community?p=KMPH
Durchsuchen
Zevra - ADHS - A Star is born
